Erbevio3
Payments companies reported to CMS as associated with Erbevio3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Erbevio3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Erbevio3
These are the largest totals companies reported as associated with Erbevio3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sandeep Singh | Murray, UT | Gastroenterology (Internal Medicine) | $437.37 |
| Neil Sharma | Gilbert, AZ | Gastroenterology (Internal Medicine) | $175.04 |
| Paul Leonor | Los Angeles, CA | Gastroenterology (Internal Medicine) | $175.00 |
| Kendrick Che | Loma Linda, CA | Gastroenterology (Internal Medicine) | $175.00 |
| Murat Akyildiz | Greenville, SC | Transplant Hepatology | $157.98 |
| Max Goldman | San Francisco, CA | Gastroenterology (Internal Medicine) | $120.00 |
| Allison Horan | San Francisco, CA | Psychiatry | $120.00 |
| Lawrence Levy | San Diego, CA | Pediatrics | $120.00 |
| Allison Ibarra | San Diego, CA | Hospitalist | $120.00 |
| Fady Youssef | San Diego, CA | Gastroenterology (Internal Medicine) | $120.00 |
Prescribed Erbevio3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.